Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology L Piccoli, YJ Park, MA Tortorici, N Czudnochowski, AC Walls, ... Cell 183 (4), 1024-1042. e21, 2020 | 1291 | 2020 |
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift E Cameroni, JE Bowen, LE Rosen, C Saliba, SK Zepeda, K Culap, ... Nature 602 (7898), 664-670, 2022 | 1112 | 2022 |
Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 697 | 2021 |
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021 | 559 | 2021 |
Staphylococcus aureus: new evidence for intracellular persistence C Garzoni, WL Kelley Trends in microbiology 17 (2), 59-65, 2009 | 559 | 2009 |
SARS-CoV-2 immune evasion by the B. 1.427/B. 1.429 variant of concern M McCallum, J Bassi, A De Marco, A Chen, AC Walls, J Di Iulio, ... Science 373 (6555), 648-654, 2021 | 509 | 2021 |
Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study SA Guler, L Ebner, C Aubry-Beigelman, PO Bridevaux, M Brutsche, ... European respiratory journal 57 (4), 2021 | 424 | 2021 |
Broad betacoronavirus neutralization by a stem helix–specific human antibody D Pinto, MM Sauer, N Czudnochowski, JS Low, MA Tortorici, MP Housley, ... Science 373 (6559), 1109-1116, 2021 | 284 | 2021 |
Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study J Coussement, ... Reviews of Infectious Diseases 63 (3), 338-345, 2016 | 195 | 2016 |
A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells C Garzoni, P Francois, A Huyghe, S Couzinet, C Tapparel, Y Charbonnier, ... BMC genomics 8, 1-14, 2007 | 192 | 2007 |
Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study N Khanna, L Elzi, NJ Mueller, C Garzoni, M Cavassini, CA Fux, ... Clinical infectious diseases 48 (10), 1459-1466, 2009 | 172 | 2009 |
Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study C Van Delden, S Stampf, HH Hirsch, O Manuel, P Meylan, A Cusini, ... Clinical infectious diseases 71 (7), e159-e169, 2020 | 166 | 2020 |
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective … M Reinwald, JT Silva, NJ Mueller, J Fortún, C Garzoni, JW de Fijter, ... Clinical Microbiology and Infection 24, S53-S70, 2018 | 164 | 2018 |
Candida parapsilosis endocarditis: a comparative review of the literature C Garzoni, VA Nobre, J Garbino European journal of clinical microbiology & infectious diseases 26, 915-926, 2007 | 128 | 2007 |
Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2 JS Low, D Vaqueirinho, F Mele, M Foglierini, J Jerak, M Perotti, ... Science 372 (6548), 1336-1341, 2021 | 125 | 2021 |
First experience of SARS‐CoV‐2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study J Tschopp, AG L'Huillier, M Mombelli, NJ Mueller, N Khanna, C Garzoni, ... American Journal of Transplantation 20 (10), 2876-2882, 2020 | 125 | 2020 |
Atypical infections in tsunami survivors C Garzoni, S Emonet, L Legout, R Benedict, P Hoffmeyer, L Bernard, ... Emerging infectious diseases 11 (10), 1591, 2005 | 120 | 2005 |
Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients O Manuel, G Kralidis, NJ Mueller, HH Hirsch, C Garzoni, C Van Delden, ... American journal of transplantation 13 (9), 2402-2410, 2013 | 119 | 2013 |
Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor–derived infections O Len, C Garzoni, C Lumbreras, I Molina, Y Meije, A Pahissa, P Grossi, ... Clinical Microbiology and Infection 20, 10-18, 2014 | 113 | 2014 |
The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... BioRxiv, 2020.11. 04.355842, 2020 | 108 | 2020 |